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Correction
It has come to our attention that since publication of
our article [1], in the body of the article the term
androstenedione has been used in error. The experi-
ments in this study used androstanedione as a test sub-
strate. Androstenedione was not used in any
experiments. This error does not in any way invalidate
the conclusion of the paper that aldo-keto reductases of
the mouse and human 1C-subfamilies lack functional
and expression homology. The authors apologise for any
confusion caused.
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